Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Mcgrath currently holds 88,762 shares of Atara Biotherapeutics, Inc. (ATRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Mcgrath has been a net seller of ATRA stock. They have purchased $0 and sold $5.8M worth of shares.
John Mcgrath's most recent insider trade was on Mar 20, 2018, when they sold 3,000 shares at $38.83 per share.
John Mcgrath serves as Executive at Atara Biotherapeutics, Inc. (ATRA). They have executed 86 insider transactions totaling $5.8M over their tenure at the company.
John Mcgrath holds the position of Executive at Atara Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John Mcgrath has shown a selling trading pattern, with $0 in total purchases and $5.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Mcgrath was on Jan 12, 2018, when they sold $750.0K worth of ATRA shares. This transaction involved 30,000 shares at $25.00 per share.
John Mcgrath currently owns 88,762 shares of Atara Biotherapeutics, Inc. (ATRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Mcgrath's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Mcgrath has 86 Form 4 filings on record as an insider at Atara Biotherapeutics, Inc..
Set alerts for John Mcgrath and 40,000+ other insiders.